Search - tctmd.com

Displaying 41 - 60 of 390

Sort: Relevancy | Date

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

Presentation TCT 2024

Cryotherapy For Vulnerable Plaque Stabilization: Preliminary Report From Polarstar, A First-In-Human Study

Presenter: Frederic Bouisset

October 30, 2024

Presentation TCT 2024

Vulnerable: Beyond the Plaque, Focus on the Patient

Presenter: Binita Shah

October 30, 2024

Presentation TCT 2024

Vulnerable Plaque: What’s Next?

Presenter: Gregg Stone

October 30, 2024

Presentation TCT 2024

Is the Presence of Vulnerable Plaque With Non-invasive Imaging Relevant?

Presenter: Bjorn Redfors

October 30, 2024

Presentation TCT 2024

Seeing is Believing: Using Intracoronary Imaging to Identify Vulnerable Plaque

Presenter: Farouc Jaffer

October 30, 2024

Presentation TCT 2024

TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk

Presenter: Ryo Hikida

October 29, 2024

Presentation TCT 2024

TCT 1020: A Preliminary Exploration of Dual-Frequency IVUS Imaging for the Assessment of Plaque Vulnerability Through Lipid and Fibrous Cap Characterization

Presenter: Teng Ma

October 29, 2024

Presentation TCT 2024

TCT 355: PrevaLence of CoronAry ArTery Anomalies Among HispaNics in the US-Mexico Border Region: pLATINum Study

Presenter: Adriana Mares

October 29, 2024

Presentation TCT 2024

TCT 1018: Plaque Risk Is Directly Related to the Type and Number of Combined Vulnerability Features: Insights From a Pooled Patient Level Analysis From COMBINE FFR_OCT and PECTUS-OBS Studies

Presenter: Elvin Kedhi

October 29, 2024

Presentation TCT 2024

TCT 1019: Coronary Plaque Characteristics Assessed by Optical Coherence Tomography and Plasma Lipoprotein (a) Levels in Patients With Acute Coronary Syndrome

Presenter: Francesca Maria Di Muro

October 29, 2024

Presentation TCT 2024

TCT 1012: Pre-Emptive PCI in Vulnerable Coronary Plaques Reduces Biomechanical and Anatomic High-Risk Features: The PROSPECT ABSORB Trial

Presenter: Diaa Hakim

October 29, 2024

Presentation TCT 2024

TCT 1017: First-in-Human Intracoronary Structural-Molecular Imaging for Multi-Targeted Characterization of High-Risk Plaques in Patients With Coronary Artery Disease

Presenter: Dong Oh Kang

October 29, 2024

Presentation TCT 2024

TCT 1016: Targeted Intravascular Photoactivation Guided by Multimodal OCT-NIRF Imaging on Atherosclerotic Plaque

Presenter: Jin Hyuk Kim

October 29, 2024

Presentation TCT 2024

TCT 1014: Lipid-Rich Non-Culprit Lesions Demonstrate Less Favorable Changes in Plaque Volume During the First Weeks After ACS

Presenter: Jonathan Los

October 29, 2024

Presentation TCT 2024

TCT 1013: Predictors of Cardiac Events from Vulnerable Coronary Plaque: Insight From PREVENT Trial

Presenter: Seong-Bong Wee

October 29, 2024

Presentation TCT 2024

TCT 1015: Cryotherapy for Vulnerable Plaque Stabilization: Preliminary Report From Polarstar: A First-In-Human Study

Presenter: Bouisset Frederic

October 29, 2024

Presentation TCT 2024

Con

Presenter: Gary Mintz

October 28, 2024

Presentation TCT 2024

Pro

Presenter: Duk-Woo Park

October 28, 2024

Presentation TCT 2024

TCT 1007: Computational Fluid Dynamics Analysis of the Optical Coherence Tomography Verified Thin Cap Fibroatheroma: Subanalysis From the COMBINE OCT-FFR Study

Presenter: Magda Roleder-Dylewska

October 28, 2024

Advertisement

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Cryotherapy For Vulnerable Plaque Stabilization: Preliminary Report From Polarstar, A First-In-Human Study

Vulnerable: Beyond the Plaque, Focus on the Patient

Vulnerable Plaque: What’s Next?

Is the Presence of Vulnerable Plaque With Non-invasive Imaging Relevant?

Seeing is Believing: Using Intracoronary Imaging to Identify Vulnerable Plaque

TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk

TCT 1020: A Preliminary Exploration of Dual-Frequency IVUS Imaging for the Assessment of Plaque Vulnerability Through Lipid and Fibrous Cap Characterization

TCT 355: PrevaLence of CoronAry ArTery Anomalies Among HispaNics in the US-Mexico Border Region: pLATINum Study

TCT 1018: Plaque Risk Is Directly Related to the Type and Number of Combined Vulnerability Features: Insights From a Pooled Patient Level Analysis From COMBINE FFR_OCT and PECTUS-OBS Studies

TCT 1019: Coronary Plaque Characteristics Assessed by Optical Coherence Tomography and Plasma Lipoprotein (a) Levels in Patients With Acute Coronary Syndrome

TCT 1012: Pre-Emptive PCI in Vulnerable Coronary Plaques Reduces Biomechanical and Anatomic High-Risk Features: The PROSPECT ABSORB Trial

TCT 1017: First-in-Human Intracoronary Structural-Molecular Imaging for Multi-Targeted Characterization of High-Risk Plaques in Patients With Coronary Artery Disease

TCT 1016: Targeted Intravascular Photoactivation Guided by Multimodal OCT-NIRF Imaging on Atherosclerotic Plaque

TCT 1014: Lipid-Rich Non-Culprit Lesions Demonstrate Less Favorable Changes in Plaque Volume During the First Weeks After ACS

TCT 1013: Predictors of Cardiac Events from Vulnerable Coronary Plaque: Insight From PREVENT Trial

TCT 1015: Cryotherapy for Vulnerable Plaque Stabilization: Preliminary Report From Polarstar: A First-In-Human Study

Con

Pro

TCT 1007: Computational Fluid Dynamics Analysis of the Optical Coherence Tomography Verified Thin Cap Fibroatheroma: Subanalysis From the COMBINE OCT-FFR Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content